|
Delayed
Sao Paulo
03:20:58 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 77.82 BRL | +5.18% |
|
+17.77% | +35.74% |
| 12:53pm | Gilead's HIV Franchise Supports Growth Outlook, RBC Says | MT |
| 10:06am | UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy Rating | MT |
| Market Cap | 205B 1,115B 184B 169B 153B 287B 19,498B 292B 2,017B 810B 10,257B 771B 754B 32,345B | P/E 2026 * |
-47.6x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 227B 1,231B 203B 187B 169B 316B 21,518B 322B 2,226B 894B 11,319B 850B 832B 35,696B | EV / Sales 2026 * |
7.37x | EV / Sales 2027 * | 6.66x |
| Free-Float |
99.89% | Yield 2026 * |
1.99% | Yield 2027 * | 2.03% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +5.01% | ||
| 1 week | +17.58% | ||
| Current month | +17.83% | ||
| 1 month | +20.80% | ||
| 3 months | +40.35% | ||
| 6 months | +40.97% | ||
| Current year | +35.53% |
| 1 week | 69.7 |  | 77.7 |
| 1 month | 59.28 | | 77.7 |
| Current year | 52.08 | | 77.7 |
| 1 year | 52.08 | | 77.7 |
| 3 years | 27.26 | | 77.7 |
| 5 years | 22.04 | | 77.7 |
| 10 years | 17.05 | | 77.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.01% | +17.58% | - | - | 205B | |
| +3.51% | +11.66% | +68.38% | +151.37% | 1,224B | |
| +0.45% | +4.70% | +46.11% | +87.86% | 662B | |
| +1.49% | +3.79% | +29.92% | +108.94% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.71% | +3.38% | +74.06% | +46.26% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.95% | +7.11% | +61.13% | +78.77% | 249B | |
| +4.00% | +10.55% | +45.65% | +121.82% | 205B | |
| Average | +2.82% | +2.59% | +47.33% | +84.10% | 464.09B | |
| Weighted average by Cap. | +2.56% | +3.04% | +51.64% | +99.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.76B 167B 27.55B 25.34B 22.96B 42.93B 2,921B 43.73B 302B 121B 1,537B 115B 113B 4,846B | 32.89B 179B 29.46B 27.1B 24.55B 45.89B 3,123B 46.75B 323B 130B 1,643B 123B 121B 5,181B |
| Net income | -4.38B -23.76B -3.92B -3.6B -3.27B -6.1B -415B -6.22B -42.98B -17.26B -219B -16.42B -16.07B -689B | 10.28B 55.83B 9.21B 8.47B 7.67B 14.35B 976B 14.61B 101B 40.55B 514B 38.59B 37.77B 1,620B |
| Net Debt | 21.27B 116B 19.05B 17.52B 15.88B 29.68B 2,020B 30.24B 209B 83.89B 1,062B 79.83B 78.13B 3,351B | 13.62B 73.96B 12.2B 11.22B 10.17B 19B 1,293B 19.36B 134B 53.71B 680B 51.11B 50.03B 2,145B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | R$77.82 | +5.18% | 4 |
| 26-10-29 | R$73.99 | +2.94% | 458 |
| 26-10-28 | R$71.88 | +1.54% | 1,112 |
| 26-10-27 | R$70.79 | -0.94% | 146 |
| 26-10-26 | R$71.46 | +8.14% | 109 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- GILD34 Stock
Select your edition
All financial news and data tailored to specific country editions
